Norway Antibiotic Resistance Market Size & Outlook

Name: Norway Antibiotic Resistance Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The antibiotic resistance market in Norway is expected to reach a projected revenue of US$ 28.5 million by 2030. A compound annual growth rate of 4.6% is expected of Norway antibiotic resistance market from 2024 to 2030.

Pharmaceuticals
- Infectious Disease Treatment
  - Antibiotic Resistance Market Outlook

Norway antibiotic resistance disease outlook (Revenue, USD million, 2018-2030)
- cUTI
- CDI
- ABSSSI
- HABP
- CABP
- cIAI
- BSI
Norway antibiotic resistance pathogen outlook (Revenue, USD million, 2018-2030)
- E.coli
- klebsiella pneumoniae
- P. aeruginosa
- S. aureus
- A. baumannii
- Strep. Pneumoniae
- H. influenzae
- CDI
- Enterococcus fecium
Norway antibiotic resistance drug class outlook (Revenue, USD million, 2018-2030)
- Oxazolidinones
- Lipoglycopeptides
- Tetracyclines
- Combination therapies
- Cephalosporins
- Other drug classes
Norway antibiotic resistance mechanism of action outlook (Revenue, USD million, 2018-2030)
- Protein Synthesis Inhibitors
- Cell Wall Synthesis Inhibitors
- RNA Synthesis Inhibitors
- DNA Synthesis Inhibitors
- Other mechanism of actions
Norway antibiotic resistance distribution channel outlook (Revenue, USD million, 2018-2030)
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies

Norway Antibiotic Resistance Market Size & Outlook

Data Tree

Sign up - it's easy, and free!